A recent NPR-Marist poll reveals that independent voters claim their support for former President Donald Trump remains unchanged or has increased following his conviction in New York City. The detailed …
"rally"
-
-
Former President Donald Trump is reportedly considering an advisory role for billionaire entrepreneur Elon Musk, should he win the November general election. This development comes as Trump, the presumptive Republican …
-
Republican governors across the United States have joined forces to oppose proposals that would significantly increase the World Health Organization’s (WHO) authority over U.S. health policies. These proposals, currently under …
-
In a shocking revelation, Dr. David Morens, a senior adviser to the director of the National Institute of Allergy and Infectious Diseases (NIAID), has been implicated in an email tampering …
-
A recent study from the Centers for Disease Control and Prevention (CDC) indicates a concerning rise in stroke prevalence among Americans under 65, a demographic traditionally less affected by this …
-
As inflation persists as a major issue for the U.S. economy, small businesses are facing significant challenges. The National Federation of Independent Businesses (NFIB) recently revealed that inflation remains the …
-
Money
New Report Exposes Bias: 70% of Banks Allegedly Target Clients for Conservative, Religious Views
A new report indicates that 70% of U.S. banks allegedly target clients based on their political and religious beliefs. The report is part of an ongoing investigation by the U.S. …
-
Florida Governor Ron DeSantis has agreed to actively campaign for former President Donald Trump following a private meeting in Miami. A significant reconciliation between the two Republican heavyweights after a …
-
In a powerful op-ed published in the New York Post, Senator Marco Rubio voices a stark warning about TikTok, the popular social media app owned by ByteDance, which is under …
-
A study published by The BMJ has raised concerns about the efficacy and added benefits of many cancer drugs approved by the European Medicines Agency (EMA) between 1995 and 2020. …